Newell-Price J., Trainer P.J., Besser G.M., Grossman A.B. The diagnosis and differential diagnosis of Cushing’s and pseudo-Cushing’s states. Endocr. Rev. 1998; 19(5): 647-72.
Bertagna X., Guignat L., Groussin L., Bertherat J. Cushing's disease. Best Pract. Res. Clin. Endocrinol. Metab. 2009; 23(5): 607-23.
Arnaldi G., Angeli A., Atkinson A.B., Bertagna X., Cavagnini F., Chrousos G.P. et al. Diagnosis and complications of Cushing's syndrome: a consensus statement. J. Clin. Endocrinol. Metab. 2003; 88(12): 5593-602.
Sharma S.T., Nieman L.K., Feelders R.A. Cushing's syndrome: epidemiology and developments in disease management. Clin. Epidemiol. 2015; 7: 281-93.
Invitti C., Pecori Giraldi F., De Martin M., Cavagnini F. Diagnosis and management of Cushing’s syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the pathophysiology of the hypotalamic-pituitary-adrenal axis. J. Clin. Endocrinol. Metab. 1999; 84(2): 440-8.
Clayton R.N., Raskauskiene D., Reulen R.C., Jones P.W. Mortality and morbidity in Cushing’s disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature. J. Clin. Endocrinol. Metab. 2011; 96(3): 632-42.
Abellán Galiana P., Fajardo Montañana C., Riesgo Suárez P.A., Gómez Vela J., Escrivá C.M., Lillo V.R. Predictors of long-term remission after transsphenoidal surgery in Cushing’s disease. Endocrinol. Nutr. 2013; 60(8): 475-82.
Biller B.M., Grossman A.B., Stewart P.M., Melmed S., Bertagna X., Bertherat J. et al. Treatment of adrenocorticotrop independent Cushing’s syndrome: a consensus statement. J. Clin. Endocrinol. Metab. 2008; 93(7): 2454-62.
Hameed N., Yedinak C.G., Brzana J., Gultekin S.H., Coppa N.D., Dogan A. et al. Remission rate after transsphenoidal surgery in patients with pathologically confirmed Cushing’s disease, the role of cortisol, ACTH assessment and immediate reoperation: a large single center experience. Pituitary. 2013; 16(4): 452-8.
Petersenn S., Beckers A., Ferone D., van der Lely A., Bollerslev J., Boscaro M. et al. Outcomes in patients with Cushing’s disease undergoing transsphenoidal surgery: systematic review assessing criteria used to define remission and recurrence. Eur. J. Endocrinol. 2015; 172(6): R227-39.
Hofmann B.M., Hlavac M., Martinez R., Buchfelder M., Muller O.A., Fahlbusch R. Long-term results after microsurgery for Cushing disease: experience with 426 primary operations over 35 years. J. Neurosurg. 2008; 108(1): 9-18.
Mathioudakis N., Pendleton С., Quinones-Hinojosa А., Wand G.S., Salvatori R. ACTH-secreting pituitary adenomas: size does not correlate with hormonal activity. Pituitary. 2012; 15(4): 526-32.
Fomekong E., Maiter D., Grandin C., Raftopoulos C. Outcome of transsphenoidal surgery for Cushing's disease: a high remission rate in ACTH-secreting macroadenomas. Clin. Neurol. Neurosurg. 2009; 111(5): 442-9.
Esposito F., Dusick J.R., Cohan P., Moftakhar P., McArthur D., Wang C. et al. Clinical review: Early morning cortisol levels as a predictor of remission after transsphenoidal surgery for Cushing’s disease. J. Clin. Endocrinol. Metab. 2006; 91(1): 7-13.
Pendharkar A.V., Sussman E.S., Ho A.L., Hayden Gephart M.G., Katznelson L. Cushing’s disease: predicting long-term remission after surgical treatment. Neurosurg. Focus. 2015; 38(2): E13.
Lindsay J.R., Oldfield E.H., Stratakis C.A., Nieman L.K. The postoperative basal cortisol and CRH tests for prediction of long-term remission from Cushing’s disease after transsphenoidal surgery. J. Clin. Endocrinol. Metab. 2011; 96(7): 2057-64.
Carrasco C.A., Coste J., Guignat L., Groussin L., Dugué M.A., Gaillard S. Midnight salivary cortisol determination for assessing the outcome of transsphenoidal surgery in Cushing’s disease. J. Clin. Endocrinol. Metab. 2008; 93(12): 4728-34.
Srinivasan L., Laws E.R., Dodd R.L., Monita M.M., Tannenbaum C.E., Kirkeby K.M. et al. The dynamics of post-operative plasma ACTH values following transsphenoidal surgery for Cushing’s disease. Pituitary. 2011; 14(4): 312-7.
Alwani R.A., de Herder W.W., van Aken M.O., van den Berge J.H., Delwel E.J., Dallenga A.H. Biochemical predictors of outcome of pituitary surgery for Cushing’s disease. Neuroendocrinology. 2010; 91(2): 169-78.
Colombo P., Dall’Asta C., Barbetta L., Re T., Passini E., Faglia G. et al. Usefulness of the desmopressin test in the postoperative evaluation of patients with Cushing’s disease. Eur. J. Endocrinol. 2000; 143(2): 227-34.
Romanholi D.J., Machado M.C., Pereira C.C., Danilovic D.S., Pereira M.A., Cescato V.A. et al. Role for postoperative cortisol response to desmopressin in predicting the risk for recurrent Cushing’s disease. Clin. Endocrinol. (Oxf). 2008; 69(1): 117-22.
Le Marc’hadour P., Muller M., Albarel F., Coulon A.L., Morange I., Martinie M. et al. Postoperative follow-up of Cushing’s disease using cortisol, desmopressin and coupled dexamethasone-desmopressin tests: a head-to-head comparison. Clin. Endocrinol. (Oxf). 2015; 83(2): 216-22.
Liddle G.W. Tests of pituitary-adrenal suppressibility in the diagnosis of Cushing’s syndrome. J. Clin. Endocrinol. Metab. 1960; 20: 1539-60.
Suda T., Kageyama K., Nigawara T., Sakihara S. Evaluation of diagnostic tests for ACTH-dependent Cushing's syndrome. Endocr. J. 2009; 56(3): 469-76.
Aron D.C., Raff H., Findling J.W. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing’s syndrome. J. Clin. Endocrinol. Metab. 1997; 82(6): 1780-5.
Barbot M., Trementino L., Zilio M., Ceccato F., Albiger N., Daniele A. et al. Second-line tests in the differential diagnosis of ACTH-dependent Cushing’s syndrome. Pituitary. 2016; 19(5): 488-95.
Flack M.R., Oldfield E.H., Cutler G.B. Jr, Zweig M.H., Malley J.D., Chrousos G.P. et al. Urine free cortisol in the high-dose dexamethasone suppression test for the differential diagnosis of the Cushing syndrome. Intern. Med. 1992; 116(3): 211-7.
Гуссаова Н.В., Савелло А.В., Цой У.А., Черебилло В.Ю., Рязанов П.А., Митрофанова Л.Б., Гринёва Е.Н. Опыт применения катетеризации пещеристых и нижних каменистых синусов в дифференциальной диагностике АКТГ-зависимого гиперкортицизма. Трансляционная медицина. 2015; 2-3(31-32): 39-47. {Gussaova N.V., Savello A.V., Tsoy U.A., Cherebillo V.Yu., Ryazanov P.A., Mitrofanova L.B., Grineva E.N. Exerience in the application of catheterization of the cavernous and inferior petrosal sinuses in differential diagnosis of ACTH-dependent hypercorticoidism. Translyatsionnaya meditsina. 2015; [2-3(31-32)]: 39-47.} (in Russian)
Nieman L.K., Biller B.M., Findling J.W., Newell-Price J., Savage M.O., Stewart P.M. et al. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 2008; 93(5): 1526-40.
Papanicolaou D.A., Yanovski J.A., Cutler Jr. G.B., Chrousos G.P., Nieman L.K. A single midnight serum cortisol measurement distinguishes Cushing’s syndrome from pseudo-Cushing states. J. Clin. Endocrinol. Metab. 1998; 83(4): 1163-7.
Lambert J.K., Goldberg L., Fayngold S., Kostadinov J., Post K.D., Geer E.B. Predictors of mortality and long-term outcomes in treated Cushing’s disease: a study of 346 patients. J. Clin. Endocrinol. Metab. 2013; 98(3): 1022-30.
Ayala A., Manzano A.J. Detection of recurrent Cushing’s disease: proposal for standardized patient monitoring following transsphenoidal surgery. J. Neurooncol. 2014; 119(2): 235-42.
Blevins L.S. Jr., Christy J.H., Khajavi M., Tindall G.T. Outcomes of therapy for Cushing’s disease due to adrenocorticotropin-secreting pituitary macroadenomas. J. Clin. Endocrinol. Metab. 1998; 83(1): 63-7.